Bio Rad Laboratories Inc (NYSE:BIO) over-valued by 13%
Website | http://www.bio-rad.com/ |
Sector | Healthcare |
Industry | Medical Devices |
Fiscal Year End | Dec 31, 2020 |
Market Cap | $18,814,611,456 |
Beta | 0.807501 |
Average Volume | $189,707 |
Last Dividend | 0% |
Price on Feb 16, 2021 | $630.13 |
Autochartist™ Valuation | $546.27 |
Conclusion |
13% over-valued |
Download Report |